Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcriptome and Metabolic Analyses of CHAPLE Disease Patients With or Without Eculizumab Treatment

NCT03950804 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT03950804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03950804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcriptome and Metabolic Analyses of CHAPLE Disease Patients With or Without Eculizumab Treatment
Lead sponsor
Marmara University
Phase
Observational
Overall status
Unknown status
Start date
June 15, 2018
Completion date
June 15, 2020
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cd55 - cluster of differentiation antigen 55 deficiency, complement regulatory factor defect, primary intestinal lymphangiectasis, protein-losing enteropathies